Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Cash-and-Short-Term-Investments" stands at 18.21 Billion United States Dollars as of 09/30/2025, the highest value since 06/30/2014.
As of the end of Merck & Company Inc's third quarter, the item "Cash and Short Term Investments" stands at 18.21 Billion USD. This represents an increase of 111.25 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 24.81 percent compared to the value the year prior.
The 1 year change in percent is 24.81.
The 3 year change in percent is 61.93.
The 5 year change in percent is 147.61.
The 10 year change in percent is 50.67.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash and Short Term Investments | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash and Short Term Investments | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash and Short Term Investments | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash and Short Term Investments | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash and Short Term Investments | 280,205,508,085.11 |